Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 5/20 | 0.43 |
| ▸ | FNTA | P49354 | 12/20 | 0.38 |
| ▸ | FNTB | P49356 | 10/20 | 0.38 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18796260 | 1.00 | BTN3A1 (0.43) | BTN3A1FNTAFNTBPGGT1BPPARD | |
| Crotyl Pyrophosphate SCHEMBL2513892 | 0.84 | BTN3A1 (0.60) | BTN3A1FNTAFNTBPGGT1B | |
| Crotyl Pyrophosphate SCHEMBL14993578 | 0.84 | BTN3A1 (0.60) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL5852321 | 0.83 | BTN3A1 (0.42) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL6058114 | 0.83 | BTN3A1 (0.42) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL15675956 | 0.78 | BTN3A1 (0.37) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL18796261 | 0.78 | BTN3A1 (0.38) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL27930424 | 0.78 | BTN3A1 (0.38) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL28575777 | 0.76 | PPARD (0.38) | BTN3A1FNTAFNTBPGGT1BPPARD | |
| SCHEMBL13268920 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4010082-B9 | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GAMMADELTA THERAPEUTICS LTD (GB) | 2026-03-04 | — | — | EP | disclosed |
| US-12312408-B2 | Multispecific anti-TCR delta variable 1 antibodies | GAMMADELTA THERAPEUTICS LTD (GB) | 2025-05-27 | — | — | US | disclosed |
| US-20240376215-A1 | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GAMMADELTA THERAPEUTICS LTD (GB) | 2024-11-14 | — | — | US | disclosed |
| EP-4269444-B1 | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GAMMADELTA THERAPEUTICS LTD (GB) | 2024-06-26 | — | — | EP | disclosed |
| EP-4265642-B1 | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GAMMADELTA THERAPEUTICS LTD (GB) | 2024-06-26 | — | — | EP | disclosed |
| EP-4265643-B1 | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GAMMADELTA THERAPEUTICS LTD (GB) | 2024-06-26 | — | — | EP | disclosed |
| EP-4269445-B1 | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GAMMADELTA THERAPEUTICS LTD (GB) | 2024-06-26 | — | — | EP | disclosed |
| EP-4269446-B1 | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GAMMADELTA THERAPEUTICS LTD (GB) | 2024-06-26 | — | — | EP | disclosed |
| US-20240132599-A1 | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | ADAPTATE BIOTHERAPEUTICS LIMITED (GB) | 2024-04-25 | — | — | US | disclosed |
| EP-4294527-A1 | ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GammaDelta Therapeutics Limited (GB) | 2023-12-27 | — | — | EP | disclosed |
| WO-2022175413-A1 | ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | ADAPTATE BIOTHERAPEUTICS LTD. (GB) | 2022-08-25 | — | — | WO | disclosed |
| EP-4013787-A1 | EX VIVO GAMMA DELTA T CELL POPULATIONS | GammaDelta Therapeutics Limited (GB) | 2022-06-22 | — | — | EP | disclosed |
| EP-4013504-A1 | NOVEL ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GammaDelta Therapeutics Limited (GB) | 2022-06-22 | — | — | EP | disclosed |
| EP-4013505-A1 | THERAPEUTIC USES OF ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GammaDelta Therapeutics Limited (GB) | 2022-06-22 | — | — | EP | disclosed |
| EP-4010082-A1 | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GammaDelta Therapeutics Limited (GB) | 2022-06-15 | — | — | EP | disclosed |
| WO-2022049550-A1 | IMMUNOTHERAPY COMPOSITION | GammaDelta Therapeutics Limited (GB) | 2022-03-10 | — | — | WO | disclosed |
| WO-2022034562-A1 | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GammaDelta Therapeutics Limited (GB) | 2022-02-17 | — | — | WO | disclosed |
| WO-2021032961-A1 | EX VIVO GAMMA DELTA T CELL POPULATIONS | GammaDelta Therapeutics Limited (GB) | 2021-02-25 | — | — | WO | disclosed |
| WO-2021032960-A1 | NOVEL ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GammaDelta Therapeutics Limited (GB) | 2021-02-25 | — | — | WO | disclosed |
| WO-2021032963-A1 | THERAPEUTIC USES OF ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | GammaDelta Therapeutics Limited (GB) | 2021-02-25 | — | — | WO | disclosed |